Title of Collaborative Activity: |
Bi-Weekly Assay subgroup for SARS-CoV-2 |
Description of Collaborative Activity: |
The objective is to share assay development activities within the government Labs |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
Year the Collaborative Activity Originated: |
2020 |
NIH Participating Institutes/Centers/Office of the Director: |
NIAID |
HHS Agency Collaborators on this Activity: |
CDC, FDA, BARDA, FDA |
